FdaApplication
ANDA 215328
Identifiers
- fda_app_no: ANDA215328
Properties
| Property | Value |
|---|---|
| applicant_name | PADAGIS ISRAEL PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2023-04-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUDESONIDE | BUDESONIDE | 2MG/ACTUATION | AEROSOL, FOAM;RECTAL |
1 product